|
DBF4B expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.909800E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.055900E-02 |
| Normal-vs-Stage2 |
4.820800E-01 |
| Normal-vs-Stage3 |
1.698620E-03 |
| Normal-vs-Stage4 |
5.008000E-01 |
| Stage1-vs-Stage2 |
3.994400E-01 |
| Stage1-vs-Stage3 |
5.914300E-02 |
| Stage1-vs-Stage4 |
6.528600E-01 |
| Stage2-vs-Stage3 |
4.094200E-02 |
| Stage2-vs-Stage4 |
9.139800E-01 |
| Stage3-vs-Stage4 |
1.899200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.604300E-02 |
| Normal-vs-AfricanAmerican |
4.109800E-01 |
| Normal-vs-Asian |
6.345200E-01 |
| Caucasian-vs-AfricanAmerican |
5.728400E-01 |
| Caucasian-vs-Asian |
1.156210E-02 |
| AfricanAmerican-vs-Asian |
2.599800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.183400E-01 |
| Normal-vs-Female |
2.206300E-02 |
| Male-vs-Female |
3.460800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.664300E-02 |
| Normal-vs-Age(41-60Yrs) |
9.331500E-02 |
| Normal-vs-Age(61-80Yrs) |
6.554200E-02 |
| Normal-vs-Age(81-100Yrs) |
7.228300E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.691000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.605600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.061400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.401000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.306200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.152600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.27180000156713E-08 |
| Classical-VS-Follicular |
9.789000E-01 |
| Classical-VS-Other |
8.386600E-01 |
| Classical-VS-Normal |
1.641170E-01 |
| Tall-VS-Follicular |
1.55929999999804E-05 |
| Tall-VS-Other |
1.675860E-02 |
| Tall-VS-Normal |
2.2490999995739E-07 |
| Follicular-VS-Other |
8.459000E-01 |
| Follicular-VS-Normal |
2.100800E-01 |
| Other-VS-Normal |
4.135200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.406810E-01 |
| Normal-vs-N1 |
9.407400E-01 |
| N0-vs-N1 |
3.614800E-01 |
|
|
